Search Results - "GIACOMETTI, Sarah"
-
1
Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice
Published in Cancer research (Chicago, Ill.) (15-11-2014)“…Defining tumor stage at diagnosis is a pivotal point for clinical decisions about patient treatment strategies. In this respect, early detection of occult…”
Get full text
Journal Article -
2
Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy
Published in Cancer research (Chicago, Ill.) (01-09-2017)“…Metronomic chemotherapy is usually associated with better tolerance than conventional chemotherapy, and encouraging response rates have been reported in…”
Get full text
Journal Article -
3
From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer
Published in International journal of nanomedicine (01-01-2018)“…Nanoparticles are of rising interest in cancer research, but in vitro canonical cell monolayer models are not suitable to evaluate their efficacy when…”
Get full text
Journal Article -
4
Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
Published in Pharmaceutics (29-11-2020)“…Prostate cancer (PCa) is the second most common cancer in men worldwide and the fifth leading cause of death by cancer. The overexpression of TCTP protein…”
Get full text
Journal Article -
5
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
Published in Journal of clinical oncology (01-01-2010)“…PURPOSE Anticipating toxicities with gemcitabine is an ongoing story, and deregulation in cytidine deaminase (CDA) could be associated with increased risk of…”
Get full text
Journal Article -
6
Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression
Published in PloS one (06-02-2009)“…Ascorbic acid (AA), or Vitamin C, is most well known as a nutritional supplement with antioxidant properties. Recently, we demonstrated that high…”
Get full text
Journal Article -
7
Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile
Published in Cancer chemotherapy and pharmacology (01-05-2009)“…We report here the case of a 19-year-old female patient who suffered from extremely severe toxicities (G4 mucitis, fever, diarrhea, alteration of general…”
Get full text
Journal Article -
8
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
Published in Oncotarget (17-10-2011)“…Recent clinical evidence revealed that the use of beta-blockers such as propranolol, prior to diagnosis or concurrently with chemotherapy, could increase…”
Get full text
Journal Article -
9
Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models
Published in International journal of pharmaceutics (10-05-2024)“…[Display omitted] The development of nanoparticles could help to improve the efficacy/toxicity balance of drugs. This project aimed to develop liposomes and…”
Get full text
Journal Article -
10
Abstract 7173: Animal pharmacokinetics of an anti-Her2+ immunoliposome of docetaxel
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Despite the success of docetaxel in combination with trastuzumab in HER2+ breast cancer, docetaxel still has serious limitations, including poor water…”
Get full text
Journal Article -
11
Abstract 1856: Pemetrexed-cisplatin-bevacizumab combo in lung cancer models: impact on tumor immunity
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Dual chemotherapy (i.e., Pemetrexed and Cisplatin, CT) plus anti-VEGF Bevacizumab could be associated with anti-PD1 such as Pembrolizumab in NSCLC patients…”
Get full text
Journal Article -
12
In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling
Published in Scientific reports (04-11-2016)“…This study aimed at evaluating the reliability and precision of Diffuse Luminescent Imaging Tomography (DLIT) for monitoring primary tumor and metastatic…”
Get full text
Journal Article -
13
Abstract 2099: Model-riven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Bevacizumab-containing protocols are all based upon the concomitant administration of the drugs given in a row. Bevacizumab is expected to induce a transient…”
Get full text
Journal Article -
14
Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters
Published in Pharmaceutical research (01-10-2014)“…ABSTRACT Purpose We have investigated the impact of particle size on the biodistribution, tumor uptake and antiproliferative efficacy of 5-FU-loaded liposomes…”
Get full text
Journal Article -
15
Abstract 4037: Optimizing the efficacy of anti-VEGF/cytotoxics/anti-PD-1 scheduling in a lung cancer mice model through B and T cells monitoring
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…The exact modalities of combinatorial regimens associating Immune Checkpoint Inhibitors (ICI) with other treatments are yet to be defined. Understanding how…”
Get full text
Journal Article -
16
Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3)
Published in Anti-cancer drugs (01-06-2020)“…Nanoparticles have been used for decades in breast cancer. More recently, anti-human epidermal receptor 2 (Her2) immunoliposomes are of rising interest…”
Get full text
Journal Article -
17
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model
Published in Cancer drug resistance (01-01-2024)“…Many tumors are refractory to immune checkpoint inhibitors, but their combination with cytotoxics is expected to improve sensitivity. Understanding how and…”
Get full text
Journal Article -
18
Abstract 3709: Characterization, in vitro and in vivo efficacy studies of docetaxel trastuzumab stealth immunoliposome in human breast cancer models
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…In HER2-positive breast cancer, the Trastuzumab + Docetaxel doublet has a significant efficacy but is hampered by frequent toxicities that could be addressed…”
Get full text
Journal Article -
19
Abstract 1857: Nanoliposomes harness tumor immunity in breast cancer models
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…The effect on the immune system of nanoparticles is poorly described. The aim of this study was to analyze in immuno-competent BalbC mice bearing or not 4T1…”
Get full text
Journal Article -
20
Abstract 3000: Impact of trastuzumab coating when prototyping immunoliposomes in breast cancer models: The more the merrier
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Background: Improving drug delivery in oncology by developing antibodies targeted nanoparticles loaded with cytotoxics is a rising strategy in oncology…”
Get full text
Journal Article